Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
28 hedge funds and large institutions have $11.2M invested in Miromatrix Medical Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
27% more funds holding
Funds holding: 22 → 28 (+6)
27% less capital invested
Capital invested by funds: $15.4M → $11.2M (-$4.23M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$808K |
| 2 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$239K |
| 3 |
GS
Gagnon Securities
New York
|
+$216K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$77.4K |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$73.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Gagnon Advisors
New York
|
-$587K |
| 2 |
SFP
Sweet Financial Partners
Fairmont,
Minnesota
|
-$534K |
| 3 |
GIPM
G2 Investment Partners Management
New York
|
-$229K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$17K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$279 |
MIRO Hedge Fund Activity: Q4 2022 in Review
28 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q4 2022, worth a combined $11.2M — down 27% from $15.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MIRO positions and 1 closed out — a net gain of 6 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $808K. The largest seller was Gagnon Advisors, cutting an estimated $587K.
- 28 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q4 2022, up from 22 in Q3 2022.
- Funds reported $11.2M of Miromatrix Medical Inc. Common Stock stock for Q4 2022, down 27% quarter-over-quarter.
- 7 funds opened new Miromatrix Medical Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of +6 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q4 2022 was Vanguard Group, an estimated $808K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q4 2022 was Gagnon Advisors, an estimated $587K sold.
Based on aggregated 13F filings for Q4 2022.